Trials / Completed
CompletedNCT06463509
Establishment and Standardization of a Platform for In-depth Tumour Profiling (TUPRO) in Patients With Melanoma
Establishment and Standardization of a Platform for In-depth Tumour Profiling (TUPRO) in Patients With Advanced Melanoma - a Prospective, Multicentric HFV Research Project/Category A
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 116 (actual)
- Sponsor
- Reinhard Dummer · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
TUPRO-Melanoma is the first project of the Tumour Profiler (TUPRO) research collaboration, which in the long-term aims to generate data that will help to understand and report the individual tumour biology and the clinical parameters for patients with advanced malignancies using innovative molecular technologies and computational analyses for in-depth molecular profiling. TUPRO-Melanoma is an exploratory project that aims to establish a comprehensive platform for in-depth tumour profiling in patients suffering from advanced melanoma. Aims of this platform are to establish logistics and algorithms for integrative analyses and discover new molecular biomarker profiles/patterns.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Establishment of an in-deepth tumor profiling platform | In-depth tumor profiling beyond genomics |
Timeline
- Start date
- 2019-01-08
- Primary completion
- 2023-05-31
- Completion
- 2023-05-31
- First posted
- 2024-06-17
- Last updated
- 2024-06-17
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT06463509. Inclusion in this directory is not an endorsement.